Literature DB >> 1683255

Inhibition of post-ischemic reperfusion injury of the small intestine by diamine oxidase.

S Koshi1, M Inoue, H Obayashi, Y Miyauchi.   

Abstract

To elucidate the role of diamines in the pathogenesis of post-ischemic reperfusion-induced tissue injury, the effect of diamine oxidase was studied in the rat whose superior mesenteric artery was occluded for 15 min followed by 30 min reperfusion. Kinetic analysis using radiolabeled albumin revealed that the mucosal permeability of the reperfused small intestine increased significantly. Histological examination of the reperfused intestine revealed a marked degeneration of its mucosal layer. Intravenous administration of diamine oxidase inhibited the reperfusion-induced increase in mucosal permeability of the intestine almost completely and preserved the structure of the small intestine. H1-antagonist chlorphenilamine and H2-antagonist famotidine also inhibited the reperfusion injury of the small intestine. These and other results suggested that extracellular diamines might play critical roles in post-ischemic reperfusion-induced injury of the small intestine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1683255     DOI: 10.1016/0304-4165(91)90271-h

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Protective effect of L-arginine preconditioning on ischemia and reperfusion injury associated with rat small bowel transplantation.

Authors:  Bin Cao; Ning Li; Yong Wang; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

Review 2.  Diamine oxidase in relation to diamine and polyamine metabolism.

Authors:  A Sessa; A Perin
Journal:  Agents Actions       Date:  1994-11

3.  Diamine oxidase knockout mice are not hypersensitive to orally or subcutaneously administered histamine.

Authors:  Matthias Karer; Marlene Rager-Resch; Teresa Haider; Karin Petroczi; Elisabeth Gludovacz; Nicole Borth; Bernd Jilma; Thomas Boehm
Journal:  Inflamm Res       Date:  2022-03-18       Impact factor: 4.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.